Ex vivo validation in CF-derived primary cells suggested that MSC1-S1s accumulate in CF and expedite adipogenic differentiation into committed preadipocytes and then dystrophic adipocytes responding to CCL20+ classical monocytes and IL-6 assessed by flow cytometry, driving aberrant formation of CF in humans. This evidence concerns the gene CCL20 and cystic fibrosis.